Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).

Clinical trial NCT00413010 · COMPLETED

Trial details

NCT number: NCT00413010
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2006-12-01
Primary completion: 2008-02-01
Enrollment: 356

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.